Allergy Therapeutics Plc (AGY) Ord GBP0.01
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
- Add to watchlist
- Create an alert
- This stock can be held in a
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
![](https://online.hl.co.uk/img/hl/layout/security-nochange-arrow.gif)
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
Annual & interim reports
Financial results for the last 5 years
Values are quoted in the stock's local currency: British pound.
Income Statement: | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 |
---|---|---|---|---|---|
£ (Millions) | £ (Millions) | £ (Millions) | £ (Millions) | £ (Millions) | |
Revenue: | 60.95 | 72.77 | 84.33 | 78.20 | 73.72 |
Operating Profit / (Loss): | (36.13) | (12.24) | 4.03 | 8.31 | 4.39 |
Net Interest: | (13.70) | (0.41) | (0.37) | (0.24) | (0.10) |
Profit Before Tax: | (49.83) | (12.66) | 3.66 | 8.07 | 4.29 |
Profit after tax from continuing operations: | (51.03) | (13.78) | 2.89 | 7.06 | 3.47 |
Discontinued Operations: | |||||
Profit after tax from discontinuing operations: | n/a | n/a | n/a | n/a | n/a |
Profit for the period: | (51.03) | (13.78) | 2.89 | 7.06 | 3.47 |
Attributable to: | |||||
Equity holders of parent company: | (51.03) | (13.78) | 2.89 | 7.06 | 3.47 |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Dividend Paid: | c n/a | c n/a | c n/a | c n/a | c n/a |
Retained Profit / (Loss) for the Financial Year: | c n/a | c n/a | c n/a | c n/a | c n/a |
Earnings per Share: | |||||
Basic: | -7.61p | -2.14p | 0.45p | 1.11p | 0.55p |
Diluted: | -7.61p | -2.14p | 0.45p | 1.05p | 0.52p |
Adjusted: | -7.61p | -2.14p | 0.45p | 1.11p | 0.55p |
Dividend per Share: | 0.00p | 0.00p | 0.00p | 0.00p | 0.00p |
Balance Sheet: | 30/06/2023 | 30/06/2022 | 30/06/2021 | 30/06/2020 | 30/06/2019 |
£ (Millions) | £ (Millions) | £ (Millions) | £ (Millions) | ||
Assets: | |||||
Non-Current Assets: | |||||
Property, Plant & Equipment: | 23.98 | 20.19 | 19.72 | 20.42 | n/a |
Intangible Assets: | 4.40 | 5.04 | 4.75 | 4.74 | n/a |
Investment Properties: | n/a | n/a | n/a | n/a | n/a |
Investments: | 5.81 | 5.96 | 5.76 | 5.90 | n/a |
Other Financial Assets: | n/a | n/a | n/a | n/a | n/a |
Other Non-Current Assets: | n/a | n/a | n/a | n/a | n/a |
34.19 | 31.19 | 30.23 | 31.05 | n/a | |
Current Assets: | |||||
Inventories: | 11.59 | 11.41 | 10.84 | 10.13 | n/a |
Trade and Other Receivables: | 7.77 | 10.47 | 6.22 | 8.08 | n/a |
Cash at Bank & In Hand: | 14.85 | 20.52 | 40.27 | 36.96 | n/a |
Current Asset Investments: | n/a | n/a | n/a | n/a | n/a |
Other Current Assets: | n/a | n/a | 0.52 | n/a | n/a |
34.21 | 42.39 | 57.86 | 55.17 | n/a | |
Other Assets: | n/a | n/a | n/a | n/a | n/a |
Total Assets: | 68.40 | 73.58 | 88.09 | 86.22 | n/a |
Liabilities: | |||||
Current Liabilities: | |||||
Borrowings: | 1.80 | 2.27 | 1.76 | 2.26 | n/a |
Other Current Liabilities: | 17.25 | 15.79 | 16.48 | 15.96 | n/a |
19.06 | 18.05 | 18.23 | 18.23 | n/a | |
Net Current Assets: | c n/a | c n/a | c n/a | c n/a | c n/a |
Non-Current Liabilities: | |||||
Borrowings: | 34.60 | 8.26 | 9.42 | 9.91 | n/a |
Provisions: | 0.49 | 0.55 | 0.62 | 0.77 | n/a |
Other Non-Current Liabilities: | 19.04 | 8.32 | 11.29 | 13.53 | n/a |
54.13 | 17.13 | 21.32 | 24.21 | n/a | |
Other Liabilities: | n/a | n/a | n/a | n/a | n/a |
Total Liabilities: | 73.18 | 35.18 | 39.55 | 42.44 | n/a |
Net Assets: | (4.78) | 38.40 | 48.53 | 43.78 | n/a |
Capital & reserves: | |||||
Share Capital: | 0.69 | 0.65 | 0.65 | 0.65 | n/a |
Share Premium Account: | 119.03 | 112.58 | 112.58 | 112.58 | n/a |
Other Reserves: | 44.22 | 43.08 | 42.71 | 43.52 | n/a |
Retained Earnings: | (168.72) | (117.91) | (107.40) | (112.96) | n/a |
Shareholders Funds: | (4.78) | 38.40 | 48.53 | 43.78 | n/a |
Minority Interests / Other Equity: | n/a | n/a | n/a | n/a | n/a |
Total Equity: | (4.78) | 38.40 | 48.53 | 43.78 | n/a |
a. Includes discontinued activities
b. Including assets due in more than one year
c. Not disclosed under IFRS
d. Total fixed assets
e. Includes borrowings
![Deal now](https://online.hl.co.uk/img/form-buttons/deal-now-button.jpg)
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.